Although our current study conducts a SOX2 knockout mice in animal models, the expression of SOX2 still reduces in BP-treated lung tissues (Figure 6E), which supports our findings in the regulation of SOX2 and collagen, thus clarifying the therapeutic effects of BP in lung fibrosis. This evidence concerns the gene SOX2 and pulmonary fibrosis.